site stats

Cingulate therapeutics llc

WebCingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. WebSep 14, 2024 · Prior to the closing of this IPO, the company will affect a “reorganization merger” in which Cingulate Inc. will acquire Cingulate Therapeutics LLC (CTx) through the merger of a wholly-owned ...

www.sec.gov

WebOct 26, 2024 · Cingulate Therapeutics, LLC is a privately-held, clinical-stage, biopharmaceutical company focused on the development of new and innovative products … WebMay 31, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products … circulatory system in malay https://primechaletsolutions.com

Cingulate Therapeutics Strengthens Leadership with Two New …

WebCingulate Inc. 1,061 followers. 2mo. Today we announce our Q3 2024 financial results and provided a clinical and business update, including updated study timelines for our lead … WebJan 9, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... WebAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 30, 2024 by and among Cingulate Therapeutics LLC, a Delaware limited liability company (“CTx”), … diamondhead premium diamond sights

Matthew N. Brams - Biography

Category:SEC.gov HOME

Tags:Cingulate therapeutics llc

Cingulate therapeutics llc

Cingulate Therapeutics Kansas City KS - Facebook

WebJul 13, 2024 · Should You Buy or Sell Cingulate Stock? Get The Latest CING Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... WebDec 8, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to …

Cingulate therapeutics llc

Did you know?

WebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug … WebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third … 10 Mar 2024 Cingulate Inc. Reports Fourth Quarter and Full Year 2024 Financial … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member …

WebSep 23, 2024 · EX-10.7 6 ex10-7.htm . Exhibit 10.7 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … WebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ …

WebApr 2, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... WebThis Joint Commercialization Agreement (this “Agreement”) is made on March 7 th 2024 (the “Effective Date”) by and between Indegene, Inc., a Delaware corporation having its place of business at Suite 104, 150 College Road W, Princeton, NJ 08540 (hereinafter referred to as “Indegene”) and Cingulate Therapeutics LLC, a Delaware ...

WebJan 1, 2024 · EX-10.10 2 ex10-10.htm . Exhibit 10.10 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of January 1, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS 66205 (the …

WebSep 23, 2024 · EX-10.4 3 ex10-4.htm . Exhibit 10.4 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … circulatory system in humans class 8WebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas. diamondhead premium sightsWebCingulate Therapeutics LLC operates as a clinical stage biopharmaceutical company. The Company focuses on the development of products for the treatment of attention deficit … circulatory system in spanishWebFounders Craig Gilgallon, Matthew Brams, Raul Silva, Shane J Schaffer. Operating Status Active. Last Funding Type Venture - Series Unknown. … circulatory system in nereisWebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas. circulatory system interact with nervousWebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from freq uently diagnosed conditions … circulatory system in orderWebCingulate Therapeutics, Kansas City, Kansas. 92 likes · 2 were here. Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage bio-pharmaceutical company foc circulatory system interaction other systems